Global Upfront Newspapers
CoverHealthNews

FACT: Studies show hydroxychloroquine does not have clinical benefits in treating COVID-19 – WHO

The World Health Organisation (WHO) says that hydroxychloroquine or chloroquine, a treatment for malaria, lupus erythematosus, and rheumatoid arthritis, has been under study as a possible treatment for COVID-19 is not safe for treatment of the virus pandemic.

Under the topic: ‘Coronavirus disease (COVID-19) advice for the public: Mythbusters,’ the WHO says that “current data shows that this drug does not reduce deaths among hospitalised COVID-19 patients, nor help people with mild or moderate disease.

“The use of hydoxychloroquine and chloroquine is accepted as generally safe for patients with malaria and autoimmune diseases, but its use where not indicated and without medical supervision can cause serious side effects and should be avoided.”

The WHO also said that “the likelihood of COVID-19 being spread on shoes and infecting individuals is very low.

“As a precautionary measure, particularly in homes where infants and small children crawl or play on floors, consider leaving your shoes at the entrance of your home.

“This will help prevent contact with dirt or any waste that could be carried on the soles of shoes.”

Advertize With Us

See Also

Multinational Joint Task Force rescues 12 hostages from Boko Haram terrorists’ enclave near Lake Chad

Global Upfront

African Development Bank appoints Wambui Gichuri, Acting Vice President Agriculture, Human And Social Development

Global Upfront

Court fines Senator Abbo N50m for assaulting woman at sex-toy shop

Global Upfront

Fuel Scarcity: Petroleum Marketers Blame ‘Logistics’ as Long Queues Persist in Abuja, Environs

Global Upfront

NAF, Army bombard Boko Haram/ISWAP terrorists’ hideouts in Gubio, Northeast Nigeria, killing scores, destroys 4 gun trucks

Global Upfront

African Leaders In Ukraine For Peace Mission, Meets With President Zelenskyy As Explosions Rock Kyiv

Global Upfront

This website uses Cookies to improve User experience. We assume this is OK...If not, please opt-out! Accept Read More